October 4, 2018
Dengue Fever Vaccine Delivered With Nanotechnology Targets All Four Virus Serotypes
A newly published study led by Stefan Metz, PhD, a research associate at the UNC School of Medicine, details how researchers used a nanoparticle vaccine platform to develop a tetravalent dengue virus vaccine capable of inducing balanced, type-specific neutralizing antibodies to each dengue virus serotype.